Top 200 Drug Matching Game is an educational quiz app for pharmacy certification prep on iOS.
Product velocity
Dormant
Daily rank 🇺🇸
#85
Education · paid
Sentiment
2.5
10 reviews
Nemesis
PTCB Exam Prep 2026 | EZPrep
The App DNA
What makes this app unique?
Users hire this app to memorize drug names and prescription codes for the PTCB exam, but the current technical friction prevents the job from being completed.
For Pharmacy technicians, nursing students, and medical professionals preparing for national certification exams.
What does it look like?
Key features
Interactive quiz mode for drug identification, gated by $5.99 purchase.
Practice module for prescription codes, gated by $21.95/month membership.
Simulated testing environment for certification prep.
How much does it cost?
Hybrid model combining one-time purchase with recurring membership tiers for web-based library access.
Velocity
Dormant developmentperformanceShow more...
Development has effectively ceased, with no new feature builds or updates released in the last year. The latest release, which focused on performance improvements, arrived 369 days ago. Given the lack of activity across both Android and iOS platforms, the app is currently in a zombie state.
Who built it?
Christopher Whitehead
12 apps tracked · Education
User Sentiment
What do users think recently?
Review voice lately leans upset.
How are ratings & reviews evolving?
What users say, by theme
- Technical failure prevents the game from launching even after following the screen rotation instructions
3 of 3 recent reviews analyzed · limited sample
Read the full review analysisUnlock 1 more frustration theme, each backed by review evidence.
Access the full report for freeCompetition
Competitive landscape for Top 200 Drug Matching Game
How's the Education market?
The app occupies a narrow educational niche, but its #96 Paid rank in the US category is threatened by a 2.5-star rating and a 369-day update drought. The lack of recent maintenance signals a high risk of abandonment relative to active competitors.
Read the market outlookThe rivals identified
By EZ Test Prep
This app directly targets the same Pharmacy Technician Certification Exam audience with a dedicated, high-frequency study platform.
- Provides comprehensive exam-style practice questions rather than simple drug-matching flashcards.
- Maintains a consistent release cadence to keep study content aligned with current exam standards.
- Offers a structured learning path that guides users through the entire certification curriculum.
Unlock the head-to-head verdict: where this rival wins, and where it loses.
Access the full report for freeThe Analyst's Read
Key takeaways for Top 200 Drug Matching Game
Where is it heading?
The pharmacy certification market is consolidating around high-frequency, subscription-based prep platforms that offer detailed rationales and analytics. This app's reliance on a static, one-time purchase model and its failure to resolve basic launch bugs leave it exposed to total market share erosion.
- The 369-day update drought suggests the product is in maintenance mode, which prevents it from keeping pace with evolving PTCB exam standards.
- Persistent launch failures on the latest build prevent users from accessing the paid content, leading to a 2.5-star rating and high churn.
The SWOT
- PTCB Advocate Educator program status validates exam alignment
- Implement free-to-try model to compete with Quizlet
Next best moves
Audit launch sequence because users report persistent crashes on startup → restore core functionality
+ 1 more prioritized moveThe counter-intuitive read
The app's biggest risk is not the competition, but its own maintenance-mode status…
Read the full takeFeature gaps
Detailed answer rationales (available in EZPrep but missing here) +1
Bottom line
The app provides a niche utility for pharmacology memorization, but technical instability and an outdated pricing model drive user churn. The PM must prioritize fixing launch regressions before attempting to scale the membership-gated study modules.
Unlock 2 critical frictions, 1 market threat, 1 more prioritized move and the analyst’s take.
Access the full report for freeSources
- [1] App Store, source
Report last updated